Bladder Cancer

The Global RAdical Cystectomy Evaluation and Management (GRACEM) Pathway: Single-Centre Prospective Observational Cohort Study Protocol - Beyond the Abstract April 14, 2025

Concomitant Chemotherapy in Trimodal Treatment of Patients with Muscle Invasive Bladder Cancer: A Systematic Review of Prospective Trials - Beyond the Abstract April 9, 2025

Gemcitabine versus Bacillus Calmette-Guerin for Intravesical Therapy in Treatment-Naïve Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer - Beyond the Abstract April 9, 2025

Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: A Nationwide Analysis of Eligibility, Utilization, and Outcomes - Beyond the Abstract April 9, 2025

En Bloc Resection of Large Bladder Tumor: Is It Feasible and Reasonable? - Beyond the Abstract April 8, 2025

Unmet Potential of Antibody-Drug Conjugates: An Evaluation of the Past, Present, and Future of Antibody-Drug Conjugate Development in Advanced Urothelial Carcinoma - Beyond the Abstract April 3, 2025

Survival after Trimodal Therapy in Octogenarians with Organ-Confined Urothelial Bladder Cancer - Beyond the Abstract March 14, 2025

A Multicenter Study of Perioperative and Functional Outcomes of Open vs. Robot Assisted Uretero-Enteric Reimplantation after Radical Cystectomy - Beyond the Abstract March 6, 2025

Multiparametric MRI and Artificial Intelligence in Predicting and Monitoring Treatment Response in Bladder Cancer - Beyond the Abstract March 5, 2025

Immediate Second Resection Versus Restage Transurethral Resection of Bladder Tumor: A Prospective Randomized Clinical Trial (IMMERSE Trial) - Beyond the Abstract February 26, 2025

Adjuvant Immunotherapy in High-Risk Muscle-Invasive Urothelial Cancer: An Updated Meta-Analysis of Randomized Controlled Trials - Beyond the Abstract February 25, 2025

Impact of Tumor Stage on Oncologic Outcomes of High-grade Bacillus Calmette-Guérin Unresponsive Non-muscle-invasive Bladder Cancer Undergoing Bladder-sparing Therapies - Beyond the Abstract February 25, 2025

Sarcopenia May Increase Cisplatin Toxicity in Bladder Cancer Patients with Borderline Renal Function - Beyond the Abstract February 24, 2025

VI-RADS-Based Algorithm for Bladder Cancer Management Randomized Retrospective Study - Beyond the Abstract February 24, 2025

Identifying Optimal Candidates for Active Surveillance in Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer - Beyond the Abstract February 18, 2025

AI Allows Pre-Screening of FGFR3 Mutational Status Using Routine Histology Slides of Muscle-Invasive Bladder Cancer - Beyond the Abstract February 6, 2025

Transformative or Transitional? Deciphering the Role of NIAGARA in Shaping Future Practice - Beyond the Abstract February 6, 2025

Assessing the Influence of Smoking on Inflammatory Markers in Bacillus Calmette Guérin Response Among Bladder Cancer Patients: A Novel Machine-Learning Approach - Beyond the Abstract February 5, 2025

Novel Delivery Mechanisms for Existing Systemic Agents and Emerging Therapies in Bladder Cancer - Beyond the Abstract February 4, 2025

Reflections on the AMBASSADOR Trial: The Role of Adjuvant Pembrolizumab in Muscle-Invasive Urothelial Carcinoma - Beyond the Abstract February 3, 2025

Page 1 of 26